Natural products to drugs: daptomycin and related lipopeptide antibiotics

RH Baltz, V Miao, SK Wrigley - Natural product reports, 2005 - pubs.rsc.org
Covering: 1953 to September 2005Daptomycin (Cubicin®) is a lipopeptide antibiotic
approved in the USA in 2003 for the treatment of skin and skin structure infections caused by …

The enzymes of β-lactam biosynthesis

RB Hamed, JR Gomez-Castellanos, L Henry… - Natural product …, 2013 - pubs.rsc.org
Covering: up to May 2012The β-lactam antibiotics and related β-lactamase inhibitors are
amongst the most important small molecules in clinical use. Most, but not all, β-lactams …

Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)

SD Bentley, KF Chater, AM Cerdeño-Tárraga… - nature, 2002 - nature.com
Streptomyces coelicolor is a representative of the group of soil-dwelling, filamentous
bacteria responsible for producing most natural antibiotics used in human and veterinary …

Structure, biosynthetic origin, and engineered biosynthesis of calcium-dependent antibiotics from Streptomyces coelicolor

Z Hojati, C Milne, B Harvey, L Gordon, M Borg, F Flett… - Chemistry & biology, 2002 - cell.com
The calcium-dependent antibiotic (CDA), from Streptomyces coelicolor, is an acidic
lipopeptide comprising an N-terminal 2, 3-epoxyhexanoyl fatty acid side chain and several …

The txtAB genes of the plant pathogen Streptomyces acidiscabies encode a peptide synthetase required for phytotoxin thaxtomin A production and pathogenicity

FG Healy, M Wach, SB Krasnoff… - Molecular …, 2000 - Wiley Online Library
Four Streptomyces species have been described as the causal agents of scab disease,
which affects economically important root and tuber crops worldwide. These species …

Exploitation of the Streptomyces coelicolor A3(2) genome sequence for discovery of new natural products and biosynthetic pathways

GL Challis - Journal of industrial microbiology and …, 2014 - academic.oup.com
Streptomyces, and related genera of Actinobacteria, are renowned for their ability to produce
antibiotics and other bioactive natural products with a wide range of applications in medicine …

Whole-genome sequencing targets drug-resistant bacterial infections

NV Punina, NM Makridakis, MA Remnev, AF Topunov - Human genomics, 2015 - Springer
During the past two decades, the technological progress of whole-genome sequencing
(WGS) had changed the fields of Environmental Microbiology and Biotechnology, and …

Global analysis of growth phase responsive gene expression and regulation of antibiotic biosynthetic pathways in Streptomyces coelicolor using DNA microarrays

J Huang, CJ Lih, KH Pan, SN Cohen - Genes & development, 2001 - genesdev.cshlp.org
The eubacterial species Streptomyces coelicolor proceeds through a complex growth cycle
in which morphological differentiation/development is associated with a transition from …

Characterization of the Pathway-Specific Positive Transcriptional Regulator for Actinorhodin Biosynthesis inStreptomyces coelicolor A3(2) as a DNA-Binding Protein

P Arias, MA Fernández-Moreno… - Journal of …, 1999 - journals.asm.org
The ActII-ORF4 protein has been characterized as a DNA-binding protein that positively
regulates the transcription of the actinorhodin biosynthetic genes. The target regions for the …

Exploiting the genetic potential of polyketide producing streptomycetes

T Weber, K Welzel, S Pelzer, A Vente… - Journal of …, 2003 - Elsevier
Streptomycetes are the most important bacterial producers of bioactive secondary
metabolites such as antibiotics or cytostatics. Due to the emerging resistance of pathogenic …